Back to Trades
O'Neill Gilmore Neil
CEODirectorCIK 0001742084
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
O'Neill Gilmore Neil, CEO, Director, has filed 4 SEC reports (2025–2026), all concentrated in Editas Medicine, Inc. (EDIT), totaling $83.7K in disclosed volume. Weighing $0 bought versus $83.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $15.6K |
| Jun 5 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $41.5K |
| Dec 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $12.1K |
| Sep 4 | EDIT Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Director | Sell | $14.5K |
4 filings